Stables R, Anderson L, Sale C, Hannon M, Dunn R, Tang J
Eur J Appl Physiol. 2024; 124(12):3767-3780.
PMID: 39154306
PMC: 11569010.
DOI: 10.1007/s00421-024-05574-4.
Maurizi A, Patrizii P, Teti A, Sutera F, Baran-Rachwalska P, Burns C
Mol Ther Nucleic Acids. 2023; 33:925-937.
PMID: 37680985
PMC: 10480457.
DOI: 10.1016/j.omtn.2023.08.020.
Perri G, Hill T, Mathers J, Walsh J, Gossiel F, Winther K
J Bone Miner Res. 2022; 37(11):2165-2173.
PMID: 36093566
PMC: 10087503.
DOI: 10.1002/jbmr.4703.
Kheiridoost-Langaroodi H, Shakouri S, Amirpour M, Iranshahi A, Farshbaf-Khalili A
J Family Reprod Health. 2022; 16(1):16-32.
PMID: 35903765
PMC: 9287118.
DOI: 10.18502/jfrh.v16i1.8590.
Migliorini F, Maffulli N, Spiezia F, Peretti G, Tingart M, Giorgino R
J Orthop Surg Res. 2021; 16(1):351.
PMID: 34059108
PMC: 8165809.
DOI: 10.1186/s13018-021-02497-0.
Biomarkers as therapy monitoring for postmenopausal osteoporosis: a systematic review.
Migliorini F, Maffulli N, Spiezia F, Tingart M, Maria P, Riccardo G
J Orthop Surg Res. 2021; 16(1):318.
PMID: 34006294
PMC: 8130375.
DOI: 10.1186/s13018-021-02474-7.
Effects of abaloparatide and teriparatide on bone resorption and bone formation in female mice.
Arlt H, Mullarkey T, Hu D, Baron R, Ominsky M, Mitlak B
Bone Rep. 2020; 13:100291.
PMID: 32637467
PMC: 7330158.
DOI: 10.1016/j.bonr.2020.100291.
A Pilot Study Showing Acute Inhibitory Effect of GLP-1 on the Bone Resorption Marker CTX in Humans.
Nissen A, Marstrand S, Skov-Jeppesen K, Bremholm L, Hornum M, Andersen U
JBMR Plus. 2019; 3(10):e10209.
PMID: 31687645
PMC: 6820456.
DOI: 10.1002/jbm4.10209.
Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives.
Kuo T, Chen C
Biomark Res. 2017; 5:18.
PMID: 28529755
PMC: 5436437.
DOI: 10.1186/s40364-017-0097-4.
Bone remodeling markers and bone metastases: From cancer research to clinical implications.
Ferreira A, Alho I, Casimiro S, Costa L
Bonekey Rep. 2015; 4:668.
PMID: 25908969
PMC: 4407509.
DOI: 10.1038/bonekey.2015.35.
Establishing reference intervals for bone turnover markers in healthy postmenopausal women in a nonfasting state.
Gossiel F, Finigan J, Jacques R, Reid D, Felsenberg D, Roux C
Bonekey Rep. 2014; 3:573.
PMID: 25228986
PMC: 4162466.
DOI: 10.1038/bonekey.2014.68.
Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis.
Kraus V, Burnett B, Coindreau J, Cottrell S, Eyre D, Gendreau M
Osteoarthritis Cartilage. 2011; 19(5):515-42.
PMID: 21396468
PMC: 3568396.
DOI: 10.1016/j.joca.2010.08.019.
NCCN Task Force Report: Bone Health in Cancer Care.
Gralow J, Biermann J, Farooki A, Fornier M, Gagel R, Kumar R
J Natl Compr Canc Netw. 2009; 7 Suppl 3:S1-32.
PMID: 19555589
PMC: 3047404.
DOI: 10.6004/jnccn.2009.0076.
Investigation of the diurnal variation in bone resorption for optimal drug delivery and efficacy in osteoporosis with oral calcitonin.
Karsdal M, Byrjalsen I, Riis B, Christiansen C
BMC Clin Pharmacol. 2008; 8:12.
PMID: 19055791
PMC: 2611964.
DOI: 10.1186/1472-6904-8-12.
